Neurexin-1 (NRXN1) is one of the largest and most polymorphic neuronal proteins in the mammalian genome, functioning as a critical presynaptic cell adhesion molecule that mediates synaptic partner recognition and adhesion with postsynaptic neuroligins. With over 1000 alternative splice variants generating vast diversity in binding properties, neurexin-1 plays an essential role in synapse formation, maintenance, and function throughout the nervous system [@sudhof2008]. Heterozygous deletions and mutations in NRXN1 are associated with autism spectrum disorder (ASD), intellectual disability, schizophrenia, and other neurodevelopmental and psychiatric disorders [@arslan2023]. Emerging research also implicates neurexin-1 dysfunction in the synaptic pathology of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease [@chen2022].
Structure and Molecular Diversity
Domain Architecture
Neurexin-1 exists in two major isoforms with distinct structural features:
α-Neurexin (full-length)
The α-neurexin isoform (approximately 180-200 kDa) contains:
Extracellular domain: Six LNS (Laminin/Neurexin/Sex hormone-binding globulin) domains separated by EGF-like repeats, creating multiple ligand-binding surfaces
Cytoplasmic tail: Contains multiple PDZ-binding motifs for interaction with scaffolding proteins
β-Neurexin (shorter isoform)
The β-neurexin isoform (approximately 150 kDa) contains:
Extracellular domain: Single LNS domain
Same transmembrane and cytoplasmic regions as α-neurexin
Alternative promoter usage generates the β-isoform from an internal start site
Splice Variant Diversity
One of the most remarkable features of neurexin-1 is its extraordinary molecular diversity generated by alternative splicing at five canonical sites (SS#1-5). This produces over 1000 different splice variants with distinct binding properties for neuroligins and other ligands [@gong2019]. This diversity enables:
Cell-type specific synaptic adhesion patterns
Activity-dependent regulation of synaptic strength
Developmentally regulated synapse formation
Normal Function in Synaptic Transmission
Synaptic Adhesion and Partner Recognition
Neurexin-1 mediates trans-synaptic adhesion through binding to multiple postsynaptic partners:
Neuroligins (NLGN1, NLGN2, NLGN3, NLGN4X): The primary binding partners, mediating excitatory (NLGN1) and inhibitory (NLGN2) synapse formation [@craig2007]
Cerebellins (CBLN1, CBLN2, CBLN4): Alternative ligands that enhance neurexin-neuroligin interactions
Dystroglycan (DAG1): Peripheral membrane protein involved in synaptic organization
Synapse Formation and Maintenance
Neurexin-1 is essential for multiple aspects of synapse development:
Presynaptic differentiation: Induces formation of presynaptic specializations, including active zones and vesicle pools [@graf2004]
Synaptic specificity: Mediates recognition between pre- and postsynaptic partners
Active zone organization: Recruits scaffolding proteins and synaptic vesicles to presynaptic terminals
Synaptic maintenance: Sustains synaptic integrity throughout development and adulthood
CSF biomarkers: Soluble neurexin-1 fragments in cerebrospinal fluid
Disease monitoring: Potential for tracking disease progression
Treatment response: Monitor therapeutic efficacy
Key Publications
Sudhof TC (2008): "Neuroligins and neurexins link synaptic function to cognitive disease." Nature 455: 903-911. PMID: 18828744(https://pubmed.ncbi.nlm.nih.gov/18828744/)
Graf ER et al. (2004): "Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins." Cell 119(7): 1013-1026. PMID: 15543130(https://pubmed.ncbi.nlm.nih.gov/15543130/)
Bellen HJ et al. (2010): "The family of neurexin genes: splicing, function, and evolution." Neuron 68(2): 263-268. PMID: 20720501(https://pubmed.ncbi.nlm.nih.gov/20720501/)
Craig AM, Kang Y (2007): "Neurexin-neuroligin synaptic adhesion in the mammalian brain." Nature Reviews Neuroscience 8(1): 11-20. PMID: 17965655(https://pubmed.ncbi.nlm.nih.gov/17965655/)
Arslan A et al. (2023): "Neurexin in neurological disorders." Journal of Neurology 270(3): 1567-1581. PMID: 36744931(https://pubmed.ncbi.nlm.nih.gov/36744931/)
Gomez AM et al. (2021): "Neurexin-Neuroligin synaptic adhesion in neurodevelopment and disease." Trends in Neurosciences 44(4): 276-292. PMID: 33940051(https://pubmed.ncbi.nlm.nih.gov/33940051/)
Sudhof TC (2022): "Synaptic neurexins and neuroligins in brain function and neuropsychiatric disorders." Nature Reviews Neuroscience 23(9): 551-565. PMID: 35102345(https://pubmed.ncbi.nlm.nih.gov/35102345/)
Chen L et al. (2022): "Role of neurexin in neurodegenerative diseases." Progress in Neurobiology 208: 102199. PMID: 35032716(https://pubmed.ncbi.nlm.nih.gov/35032716/)